Open AccessEvaluation of adverse effects of lisinopril and rosuvastatin on hematological and biochemical analytes in wistar rats
Author(s) -
Hardik Dodiya,
Vijay P. Kale,
S. Goswami,
Rajesh Sundar,
Mukul Jain
Publication year - 2013
Publication title -
toxicology international/indian journal of toxicology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.129
H-Index - 26
eISSN - 0976-5131
pISSN - 0971-6580
DOI - 10.4103/0971-6580.117261
Subject(s) - rosuvastatin , lisinopril , pharmacology , medicine , hemoglobin , hematocrit , rosuvastatin calcium , creatine kinase , endocrinology , chemistry , angiotensin converting enzyme , blood pressure
Combination therapy of lisinopril and rosuvastatin may be an important concept in developing more effective strategies to treat and prevent atherosclerosis, coronary heart disease, and co-morbid metabolic disorders. The present study was designed to evaluate toxic effects of lisinopril and rosuvastatin alone or its combination therapy on hematological and biochemical analytes in Wistar rats.